Clinical Briefs in Primary Care – March 1, 2006
March 1, 2006
View Issues
-
Clinical Briefs in Primary Care
There have been no new agents approved to treat gout for over 20 years. Because the plasma becomes supersaturated at a uric acid level of 6.0 mg/dL, it is felt that persons with a diathesis for tissue deposition of urate (gouty arthritis, tophi, or both) will optimize benefit by maintaining serum uric acid (SUA) below this level.